Pharmagen, Inc. (PHRX)

Market Cap	517.00
Revenue (ttm)	4.41M -19.9%
Net Income	-6.43M
EPS	-0.02
Shares Out	517.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,766
Average Volume	16,765
Open	0.0000
Previous Close	0.0000
Day's Range	0.0000 - 0.0000
52-Week Range	0.0000 - 0.0000
Beta	0.28
RSI	51.03
Earnings Date	n/a

About Pharmagen

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States. The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals. It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology,...

• Industry: Medical Distribution
• Sector: Healthcare
• Employees: 24
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHRX

Financial Performance

In 2013, Pharmagen's revenue was $4.81 million, an increase of 12.97% compared to the previous year's $4.26 million. Losses were -$6.46 million, 133.0% more than in 2012.